Recombinant human serum albumin (rHSA)
Recombinant human serum albumin (rHSA) replaces plasma-derived HSA (pHSA) — constrained by donor-blood supply and viral-contamination risk since the 1940s — and the first rice-derived rHSA for injection has been approved by FDA/EMA/PMDA.
How it works
This is a procurement category, not a named manufacturer's product. As a paid service, Bioecon finds suppliers for your task, agrees configuration and specification, and arranges supply; the price is on request. Bioecon may receive a fee from suppliers — this is disclosed and does not affect the portal's grades or lists.
Technology
Recombinant human serum albumin (rHSA) — Evidence, registration route, funding and suppliers are on the technology page.
Recombinant human serum albumin (rHSA) replaces plasma-derived HSA (pHSA) — constrained by donor blood supply and viral contamination risk since the 1940s — with biosynthetic production in yeast (Pichia pastoris, Hansenula polymorpha) or plant (rice endosperm) hosts: Healthgen Biotech's OsrHSA (奥福民 …
Links
- Import and registration route
- SERV — — (operator: Rosprirodnadzor, Rostechnadzor)
- Capabilities
- Contract manufacturing (CMO/CDMO) · Synthesis & conversion · Fermentation & cultivation · Formulation & blending
Related items
Other categories for this technology
Upstream — fermentation & cell culture
In the same node
3D food printing & kitchen robotics · Adaptogens and legal entheogens (nutraceutical market) · Algal protein isolates for food · Alternative honey & biosynthetic honey · Alternative proteins · Alternative thickeners & fermented gums · Amino acids for feed (lysine, methionine, threonine, tryptophan) · Antifouling bio-coatings (marine) · All →